Skip to main content
. 2020 Sep 8;21(3):265–272. doi: 10.1089/ham.2020.0026

Table 2.

The Incidence of Acute Mountain Sickness and Acute Mountain Sickness Symptoms Reported by All Climbers (n = 356)

  Day 1
Day 2
n (%) 95% CI n (%) 95% CI
AMS incidence (LLS ≥3) 85 (23.9) 19.5%–28.7% 77 (21.7) 17.5%–26.3%
 Mild 71 (20.0)   59 (16.6)  
 Moderate 14 (3.9)   17 (4.8)  
 Severe 0 (0)   1 (0.3)  
Fatigue symptoma 275 (77.3) 72.5%–81.5% 253 (71.1) 66.0%–75.7%
 Mild 164 (46.1)   146 (41.0)  
 Moderate 101 (28.4)   96 (27.0)  
 Incapacitating 10 (2.8)   11 (3.1)  
Headache symptoma 131 (36.7) 31.8%–42.0% 112 (31.5) 26.7%–36.6%
 Mild 107 (30.1)   86 (24.2)  
 Moderate 22 (6.2)   24 (6.7)  
 Incapacitating 2 (0.5)   2 (0.6)  
Dizziness symptoma 106 (29.8) 25.1%–34.8% 90 (25.3) 20.8%–30.1%
 Mild 92 (25.8)   77 (21.6)  
 Moderate 14 (4.0)   13 (3.7)  
 Incapacitating 0 (0)   0 (0)  
Gastrointestinal symptoma 45 (12.7) 9.4%–16.5% 51 (14.4) 10.8%–18.4%
 Mild 33 (9.3)   39 (11.0)  
 Moderate 6 (1.7)   7 (2.0)  
 Incapacitating 6 (1.7)   5 (1.4)  
a

Symptoms reported by all climbers, not limited to AMS sufferers only.

CI, confidence interval; LLS, Lake Louise Score of AMS.